Research Directory

Balance of power in pharmaceuticals is shifting

Read more

Highlights of the new EU Clinical Trials Regulation

Read more

Biotechs are energised - at least for now

Read more

How Britain champions medical innovation

Read more

Rare Diseases AbbVie-Shire merger could be a new beginning

Read more

What next for the EMA's transparency policy?

Read more

Stocks mostly stable amid the fireworks

Read more

How outcomes measures can improve healthcare

Read more

All roads lead to health technology assessment

Read more

Commentary: Big deals for Big Pharma

Read more